Nausea drug may unlock new clues for Diabetes-Related high blood pressure
NCT ID NCT02811055
First seen Feb 05, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This small pilot study looked at whether aprepitant, a drug used for nausea, can lower a hormone called aldosterone in people with type 2 diabetes and high blood pressure. Five participants took either aprepitant or a placebo for two weeks, then switched. The goal was to understand how the nervous system affects hormone levels, not to treat the condition directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rouen University Hospital
Rouen, France
Conditions
Explore the condition pages connected to this study.